Last 12 months
Inside the activity.
0 purchase rows · 27 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 11 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 19, 2022 Filed Apr 22, 2022 12:31 UTC |
Ray AmritDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,525 | $0.00 Strike: $78.10 | $0.00 |
DisclosureSEC source: 0001209191-22-025279 · doc4.xml · derivative · entry 2 Ray Amrit · CIK 0001924797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,525 Underlying: Common Stock · 9,525 shares Expires 2032-04-19 F3 · derivative.exercise_date: The option shall vest with respect to 1/36th of the shares monthly such that the option shall be fully vested on the third anniversary of the grant date. Read SEC document |
| April 19, 2022 Filed Apr 22, 2022 12:31 UTC |
Ray AmritDirector
|
GrantCommon Stock | 5,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025279 · doc4.xml · nonDerivative · entry 1 Ray Amrit · CIK 0001924797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,120 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/3rd of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the third anniversary of the grant date. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| April 16, 2022 Filed Apr 19, 2022 16:56 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
SaleCommon Stock | 132 | $84.55 | $11,160.60 |
DisclosureSEC source: 0001209191-22-024699 · doc4.xml · nonDerivative · entry 1 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,914 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:33 UTC |
Kassberg Thomas RichardCBO & EVP
|
SaleCommon Stock | 10,281 | $67.01 | $688,929.81 |
DisclosureSEC source: 0001209191-22-018829 · doc4.xml · nonDerivative · entry 1 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,559 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 07, 2022 Filed Mar 8, 2022 17:25 UTC |
Parschauer Karah HerdmanEVP and Chief Legal Officer
|
SaleCommon Stock | 5,140 | $62.95 | $323,563.00 |
DisclosureSEC source: 0001209191-22-016931 · doc4.xml · nonDerivative · entry 1 Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,438 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.89 to $63.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 17:25 UTC |
Fust Matthew KDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $40.37 | $0.00 |
DisclosureSEC source: 0001209191-22-016930 · doc4.xml · derivative · entry 2 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2024-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in full on on June 18, 2015. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 17:25 UTC |
Fust Matthew KDirector
|
Exercise / conversionCommon Stock | 7,500 | $40.37 | $302,775.00 |
DisclosureSEC source: 0001209191-22-016930 · doc4.xml · nonDerivative · entry 1 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 03, 2022 Filed Mar 3, 2022 23:12 UTC |
Dier MardiCFO & Executive Vice President
|
SaleCommon Stock | 420 | $64.55 | $27,111.00 |
DisclosureSEC source: 0001209191-22-015833 · doc4.xml · nonDerivative · entry 3 Dier Mardi · CIK 0001574591 · CFO & Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,808 F3 · kind: The sales on March 3, 2022 reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:07 UTC |
Kassberg Thomas RichardCBO & EVP
|
GrantStock Option (Right to Buy) · Derivative | 24,900 | $0.00 Strike: $67.37 | $0.00 |
DisclosureSEC source: 0001209191-22-015806 · doc4.xml · derivative · entry 3 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,900 Underlying: Common Stock · 24,900 shares Expires 2032-03-01 F4 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:07 UTC |
Kassberg Thomas RichardCBO & EVP
|
GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015806 · doc4.xml · nonDerivative · entry 2 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,840 F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:07 UTC |
Kassberg Thomas RichardCBO & EVP
|
SaleCommon Stock | 2,374 | $66.62 | $158,155.88 |
DisclosureSEC source: 0001209191-22-015806 · doc4.xml · nonDerivative · entry 1 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,840 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:06 UTC |
KAKKIS EMIL DDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 92,360 | $0.00 Strike: $67.37 | $0.00 |
DisclosureSEC source: 0001209191-22-015799 · doc4.xml · derivative · entry 4 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,360 Underlying: Common Stock · 92,360 shares Expires 2032-03-01 F4 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:06 UTC |
KAKKIS EMIL DDirector · President & CEO
|
GrantCommon Stock | 52,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015799 · doc4.xml · nonDerivative · entry 2 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634,226 F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:06 UTC |
KAKKIS EMIL DDirector · President & CEO
|
Tax withholdingCommon Stock | 12,162 | $67.37 | $819,353.94 |
DisclosureSEC source: 0001209191-22-015799 · doc4.xml · nonDerivative · entry 1 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 582,185 F1 · kind: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:07 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 24,900 | $0.00 Strike: $67.37 | $0.00 |
DisclosureSEC source: 0001209191-22-015802 · doc4.xml · derivative · entry 3 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,900 Underlying: Common Stock · 24,900 shares Expires 2032-03-01 F4 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:07 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015802 · doc4.xml · nonDerivative · entry 2 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,938 F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:07 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
SaleCommon Stock | 2,821 | $66.62 | $187,935.02 |
DisclosureSEC source: 0001209191-22-015802 · doc4.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,938 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:12 UTC |
Dier MardiCFO & Executive Vice President
|
GrantStock Option (Right to Buy) · Derivative | 24,900 | $0.00 Strike: $67.37 | $0.00 |
DisclosureSEC source: 0001209191-22-015833 · doc4.xml · derivative · entry 4 Dier Mardi · CIK 0001574591 · CFO & Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,900 Underlying: Common Stock · 24,900 shares Expires 2032-03-01 F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:12 UTC |
Dier MardiCFO & Executive Vice President
|
GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015833 · doc4.xml · nonDerivative · entry 2 Dier Mardi · CIK 0001574591 · CFO & Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,228 F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:12 UTC |
Dier MardiCFO & Executive Vice President
|
SaleCommon Stock | 534 | $66.62 | $35,575.08 |
DisclosureSEC source: 0001209191-22-015833 · doc4.xml · nonDerivative · entry 1 Dier Mardi · CIK 0001574591 · CFO & Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,228 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:11 UTC |
Harris ErikEVP & Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 24,900 | $0.00 Strike: $67.37 | $0.00 |
DisclosureSEC source: 0001209191-22-015830 · doc4.xml · derivative · entry 3 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,900 Underlying: Common Stock · 24,900 shares Expires 2032-03-01 F4 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:11 UTC |
Harris ErikEVP & Chief Commercial Officer
|
GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015830 · doc4.xml · nonDerivative · entry 2 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,317 F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:11 UTC |
Harris ErikEVP & Chief Commercial Officer
|
SaleCommon Stock | 2,713 | $66.62 | $180,740.06 |
DisclosureSEC source: 0001209191-22-015830 · doc4.xml · nonDerivative · entry 1 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,317 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:10 UTC |
Pinion John RichardSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 24,900 | $0.00 Strike: $67.37 | $0.00 |
DisclosureSEC source: 0001209191-22-015823 · doc4.xml · derivative · entry 3 Pinion John Richard · CIK 0001648096 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,900 Underlying: Common Stock · 24,900 shares Expires 2032-03-01 F4 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:10 UTC |
Pinion John RichardSee Remarks
|
GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015823 · doc4.xml · nonDerivative · entry 2 Pinion John Richard · CIK 0001648096 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,266 F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:10 UTC |
Pinion John RichardSee Remarks
|
SaleCommon Stock | 4,498 | $66.62 | $299,656.76 |
DisclosureSEC source: 0001209191-22-015823 · doc4.xml · nonDerivative · entry 1 Pinion John Richard · CIK 0001648096 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,266 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:09 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 7,400 | $0.00 Strike: $67.37 | $0.00 |
DisclosureSEC source: 0001209191-22-015819 · doc4.xml · derivative · entry 3 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,400 Underlying: Common Stock · 7,400 shares Expires 2032-03-01 F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:09 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
GrantCommon Stock | 3,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015819 · doc4.xml · nonDerivative · entry 2 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,046 F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. F3 · balance_after: Includes 107 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 29, 2021. F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:09 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
SaleCommon Stock | 843 | $66.62 | $56,160.66 |
DisclosureSEC source: 0001209191-22-015819 · doc4.xml · nonDerivative · entry 1 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,229 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:09 UTC |
Huang Dennis KarlSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 24,900 | $0.00 Strike: $67.37 | $0.00 |
DisclosureSEC source: 0001209191-22-015815 · doc4.xml · derivative · entry 3 Huang Dennis Karl · CIK 0001641217 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,900 Underlying: Common Stock · 24,900 shares Expires 2032-03-01 F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:09 UTC |
Huang Dennis KarlSee Remarks
|
GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015815 · doc4.xml · nonDerivative · entry 2 Huang Dennis Karl · CIK 0001641217 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,040 F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. F3 · balance_after: Includes 126 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 29, 2021. F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:09 UTC |
Huang Dennis KarlSee Remarks
|
SaleCommon Stock | 3,234 | $66.62 | $215,449.08 |
DisclosureSEC source: 0001209191-22-015815 · doc4.xml · nonDerivative · entry 1 Huang Dennis Karl · CIK 0001641217 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,914 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:08 UTC |
Parschauer Karah HerdmanEVP and Chief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 24,900 | $0.00 Strike: $67.37 | $0.00 |
DisclosureSEC source: 0001209191-22-015811 · doc4.xml · derivative · entry 3 Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,900 Underlying: Common Stock · 24,900 shares Expires 2032-03-01 F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:08 UTC |
Parschauer Karah HerdmanEVP and Chief Legal Officer
|
GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015811 · doc4.xml · nonDerivative · entry 2 Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,578 F3 · balance_after: Includes 106 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 29, 2021. F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:08 UTC |
Parschauer Karah HerdmanEVP and Chief Legal Officer
|
SaleCommon Stock | 2,886 | $66.62 | $192,265.32 |
DisclosureSEC source: 0001209191-22-015811 · doc4.xml · nonDerivative · entry 1 Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,472 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.62 to $66.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 30, 2022 Filed Feb 1, 2022 18:39 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
SaleCommon Stock | 1,657 | $66.30 | $109,859.10 |
DisclosureSEC source: 0001209191-22-005838 · doc4.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,759 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| December 10, 2021 Filed Feb 1, 2022 18:42 UTC |
Kassberg Thomas RichardCBO & EVP
|
GiftCommon Stock | 52 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-005840 · doc5.xml · nonDerivative · entry 1 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,214 F1 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| December 10, 2021 Filed Feb 1, 2022 18:41 UTC |
KAKKIS EMIL DDirector · President & CEO
|
GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-005839 · doc5.xml · nonDerivative · entry 1 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 200 Disclosed balance after: 2,209,741 Read SEC document |
| October 14, 2021 Filed Oct 14, 2021 22:33 UTC |
Dier MardiCFO & Executive Vice President
|
SaleCommon Stock | 3,261 | $81.16 | $264,662.76 |
DisclosureSEC source: 0001209191-21-060504 · doc4.xml · nonDerivative · entry 2 Dier Mardi · CIK 0001574591 · CFO & Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,762 F2 · kind: The transaction reported in this row on this Form 4 was effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.55 to $81.81 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| October 14, 2021 Filed Oct 18, 2021 22:48 UTC |
Kassberg Thomas RichardCBO & EVP
|
SaleCommon Stock | 286 | $81.14 | $23,206.04 |
DisclosureSEC source: 0001209191-21-060754 · doc4.xml · nonDerivative · entry 1 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,266 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| October 14, 2021 Filed Oct 18, 2021 22:44 UTC |
KAKKIS EMIL DDirector · President & CEO
|
Tax withholdingCommon Stock | 853 | $81.00 | $69,093.00 |
DisclosureSEC source: 0001209191-21-060749 · doc4.xml · nonDerivative · entry 1 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 594,347 F1 · kind: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| October 14, 2021 Filed Oct 18, 2021 23:02 UTC |
Bedrosian Camille LEVP and Chief Medical Officer
|
SaleCommon Stock | 359 | $81.14 | $29,129.26 |
DisclosureSEC source: 0001209191-21-060765 · doc4.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,416 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| October 14, 2021 Filed Oct 18, 2021 22:58 UTC |
Harris ErikEVP & Chief Commercial Officer
|
SaleCommon Stock | 303 | $81.14 | $24,585.42 |
DisclosureSEC source: 0001209191-21-060760 · doc4.xml · nonDerivative · entry 1 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,030 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| October 14, 2021 Filed Oct 18, 2021 22:55 UTC |
Huang Dennis KarlEVP & Chief Tech Ops Officer
|
SaleCommon Stock | 358 | $81.14 | $29,048.12 |
DisclosureSEC source: 0001209191-21-060759 · doc4.xml · nonDerivative · entry 1 Huang Dennis Karl · CIK 0001641217 · EVP & Chief Tech Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,148 F1 · kind: Represents shares sold by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| October 14, 2021 Filed Oct 18, 2021 22:53 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
SaleCommon Stock | 140 | $81.14 | $11,359.60 |
DisclosureSEC source: 0001209191-21-060756 · doc4.xml · nonDerivative · entry 2 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,072 F1 · kind: Represents shares sold by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| October 14, 2021 Filed Oct 18, 2021 22:46 UTC |
Parschauer Karah HerdmanEVP and General Counsel
|
SaleCommon Stock | 310 | $81.14 | $25,153.40 |
DisclosureSEC source: 0001209191-21-060752 · doc4.xml · nonDerivative · entry 1 Parschauer Karah Herdman · CIK 0001677455 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,358 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| October 14, 2021 Filed Oct 18, 2021 22:41 UTC |
Pinion John RichardSee Remarks
|
SaleCommon Stock | 358 | $81.14 | $29,048.12 |
DisclosureSEC source: 0001209191-21-060748 · doc4.xml · nonDerivative · entry 1 Pinion John Richard · CIK 0001648096 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,764 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 22:33 UTC |
Dier MardiCFO & Executive Vice President
|
SaleCommon Stock | 3,477 | $82.79 | $287,860.83 |
DisclosureSEC source: 0001209191-21-060504 · doc4.xml · nonDerivative · entry 1 Dier Mardi · CIK 0001574591 · CFO & Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,023 F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 16:57 UTC |
Kassberg Thomas RichardCBO & EVP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 109,734 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001209191-21-058365 · doc4.xml · derivative · entry 2 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 109,734 shares Expires 2021-11-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested with respect to 1/4th of the shares on the first anniversary of the grant date of the option and 1/48th of the shares thereafter such that the option fully vested on the fourth anniversary of the grant date. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 16:57 UTC |
Kassberg Thomas RichardCBO & EVP
|
Exercise / conversionCommon Stock | 109,734 | $0.31 | $34,017.54 |
DisclosureSEC source: 0001209191-21-058365 · doc4.xml · nonDerivative · entry 1 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.